Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s share price crossed above its fifty day moving average during trading on Monday . The stock has a fifty day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares.
Targeted Medical Pharma Price Performance
About Targeted Medical Pharma
Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.
Read More
- Five stocks we like better than Targeted Medical Pharma
- Stock Average Calculator
- The Average 401k Balance by Age Explained
- What are earnings reports?
- 3 Uranium Stocks To Gain as Microsoft Goes Nuclear to Power AI
- Comparing and Trading High PE Ratio Stocks
- Biotech Boom Ahead? Key Stocks and ETFs to Watch Now
Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.jpg?v=20230518070110&h=45&w=95&zc=2){kind=logo}
